Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas

Oncology Reports

Volumn 14, Issue 4, 2005, Pages 879-883

  Kang, Hio Chung ^a,e   Kim, Il Jin ^a   Park, Jae Hyun ^a   Shin, Yong ^a   Jang, Sang Geun ^a   Ahn, Sun A ^a   Park, Hye Won ^a   Lim, Sun Kyung ^a   Oh, Seung Keun ^b   Kim, Dae Jung ^c   Lee, Kwan Woo ^c   Choi, Young Sik ^d   Park, Young Joo ^b   Lee, Min Ro ^b   Kim, Duck Woo ^e   Park, Jae Gahb ^a,b,e  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Kosin University College of Medicine   (South Korea)

^e National Cancer Center   (South Korea)

Author keywords

Germline mutation; Pheochromocytoma; VHL; Von hippel Lindau

Indexed keywords

CATECHOLAMINE; VHL PROTEIN, HUMAN; VON HIPPEL LINDAU PROTEIN;

ADRENAL TUMOR; ADULT; ARTICLE; BIOLOGICAL MODEL; FEMALE; FRAMESHIFT MUTATION; GENETICS; GENOTYPE; HUMAN; KOREA; MALE; METABOLISM; MIDDLE AGED; MISSENSE MUTATION; MUTATION; NUCLEOTIDE SEQUENCE; PARAGANGLIOMA; PATHOLOGY; PEDIGREE; PHENOTYPE; PHEOCHROMOCYTOMA; POLYMERASE CHAIN REACTION;

ADRENAL GLAND NEOPLASMS; ADULT; CATECHOLAMINES; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GENOTYPE; GERM-LINE MUTATION; HUMANS; KOREA; MALE; MIDDLE AGED; MODELS, GENETIC; MUTATION; MUTATION, MISSENSE; PARAGANGLIOMA; PEDIGREE; PHENOTYPE; PHEOCHROMOCYTOMA; POLYMERASE CHAIN REACTION; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 33644824882     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.4.879     Document Type: Article

References (22)

1. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM and Oldfield EH: Von Hippel-Lindau disease. Lancet 361: 2059-2067, 2003. (Pubitemid 36695052)
2. Kaelin WG Jr: Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2: 673-682, 2002.
3. Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA and Morton N: Von Hippel-Lindau disease: a genetic study. J Med Genet 28: 443-447, 1991. (Pubitemid 21922636)
4. Hes FJ, Hoppener JW and Lips CJ: Clinical review 155: Pheochromocytoma in Von Hippel-Lindau disease. J Clin Endocrinol Metab 88: 969-974, 2003. (Pubitemid 36337740)
5. Bryant J, Farmer J, Kessler LJ, Townsend RR and Nathanson KL: Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 95: 1196-2204, 2003.
6. Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M, Pack S, Hurley K, Andrey C, Klausner R and Linehan WM: Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 12: 417-423, 1998. (Pubitemid 28512618)
7. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C and Eng C: Freiburg-Warsaw-Columbus Pheochromocytoma Study Group: Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346: 1459-1466, 2002.
8. Eng C, Crossey PA, Mulligan LM, Healey CS, Houghton C, Prowse A, Chew SL, Dahia PL, O'Riordan JL, Toledo SP, Smith DP, Maher ER and Ponder BAJ: Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic pheochromocytomas. J Med Genet 32: 934-937, 1995.
9. Friedrich CA: Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet 10: 763-767, 2001.
10. Ruiz-Llorente S, Bravo J, Cebrian A, Cascon A, Pollan M, Telleria D, Leton R, Urioste M, Rodriguez-Lopez R, De Campos JM, Munoz MJ, Lacambra C, Benitez J and Robledo M: Genetic characterization and structural analysis of VHL Spanish families to define genotype-phenotype correlations. Hum Mutat 23: 160-169, 2004. (Pubitemid 38200606)
11. Shin KH, Park KJ, Kim SW, Lee SH, Lee SE, Jung HW, Kim HJ and Par JG: Germline mutations of VHL gene in Korean von Hippel-Lindau disease patients. J Korean Cancer Assoc 28: 544-554, 1996.
12. Kim IJ, Kang HC, Park JH, Ku JL, Lee JS, Kwon HJ, Yoon KA, Heo SC, Yang HY, Cho BY, Kim SY, Oh SK, Youn YK, Park DJ, Lee MS, Lee KW and Park JG: RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes. Clin Cancer Res 8: 457-463, 2002.
13. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI and Yao M: Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54: 2852-2855, 1994.
14. Cybulski C, Krzystolik K, Maher ER, Richard S, Kurzawski G, Gronwald J and Lubinski J: Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene. Hum Genet 105: 333-336, 1999. (Pubitemid 29476284)
15. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, Eng C and Maher ER: Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69: 49-54, 2001. (Pubitemid 32614017)
16. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard CW III, Cornelisse CJ, Devilee P and Devlin B: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848-851, 2000. (Pubitemid 30084326)
17. Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HP, Laidlaw J and Li FP: Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55: 1092-1102, 1994. (Pubitemid 24355562)
18. Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA and Ferguson-Smith MA: Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 3: 2169-2173, 1994.
19. Vortmeyer AO, Lubensky IA, Fogt F, Linehan WM, Khettry U and Zhuang Z: Allelic deletion and mutation of the von Hipppel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am J Pathol 151: 951-956, 1997. (Pubitemid 27424304)
20. Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ and Moore AT: Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. J Med Genet 33: 328-332, 1996. (Pubitemid 26102462)
21. Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M and Kaelin WG Jr: von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum Mol Genet 10: 1019-1027, 2001. (Pubitemid 32447779)
22. Crossey PA, Eng C, Ginalska-Malinowska M, Lennard TW, Wheeler DC, Ponder BA and Maher ER: Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. J Med Genet 32: 885-886, 1995.